Antitumor Activity of Protons and Molecular Hydrogen: Underlying Mechanisms - Archive ouverte HAL Accéder directement au contenu
Article Dans Une Revue Cancers Année : 2021

Antitumor Activity of Protons and Molecular Hydrogen: Underlying Mechanisms

(1) , (1) , (1) , (1)
1

Résumé

Understanding the structure and dynamics of the various hydrogen forms has been a subject of numerous studies. Protons (H+) and molecular hydrogen (H2) in the cell are critical in a wide variety of processes. A new cancer treatment uses H2, a biologically inactive gas. Due to its small molecular weight, H2 can rapidly penetrate cell membranes and reach subcellular components to protect nuclear DNA and mitochondria. H2 reduces oxidative stress, exerts anti-inflammatory effects, and acts as a modulator of apoptosis. Exogenous H2, administered by inhalation, drinking H2-rich water, or injecting H2-rich saline solution, is a protective therapy that can be used in multiple diseases, including cancer. In particle therapy, cyclotrons and synchrotrons are the accelerators currently used to produce protons. Proton beam radiotherapy (PBT) offers great promise for the treatment of a wide variety of cancers due to the sharp decrease in the dose of radiation at a defined point. In these conditions, H2 and different types of H2 donors may represent a novel therapeutic strategy in cancer treatment.
Fichier principal
Vignette du fichier
cancers-13-00893.pdf (745.43 Ko) Télécharger le fichier
Origine : Fichiers éditeurs autorisés sur une archive ouverte

Dates et versions

hal-03409135 , version 1 (03-11-2021)

Identifiants

Citer

Luc Rochette, Marianne Zeller, Yves Cottin, Catherine Vergely. Antitumor Activity of Protons and Molecular Hydrogen: Underlying Mechanisms. Cancers, 2021, 13 (4), pp.893. ⟨10.3390/cancers13040893⟩. ⟨hal-03409135⟩
53 Consultations
22 Téléchargements

Altmetric

Partager

Gmail Facebook Twitter LinkedIn More